ArticleEuropean urology2010
Words of wisdom. Re: Phase 1 trial of high-dose exogenous testosterone in patients with castration-resistant metastatic prostate cancer. Morris MJ, Huang D, Kelly WK, et al. Eur Urol 2009;56:237-44.
Paul H LangePubMed ↗Publisher ↗
No numbers read from the abstract.